{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:55:37Z","timestamp":1787165737100,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s15010-021-01701-x","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T08:23:53Z","timestamp":1632731033000},"page":"43-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2070-3585","authenticated-orcid":false,"given":"Woon Hean","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab K.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer P.","family":"Neu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK, Ramani A, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49:591\u2013605.","journal-title":"Infection"},{"key":"1701_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"1701_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, et al. COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi. 2020;6:91.","journal-title":"J Fungi"},{"key":"1701_CR4","doi-asserted-by":"publisher","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","volume":"23","author":"D Armstrong-James","year":"2020","unstructured":"Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning DW, Johnson E, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis (CAPA). Eur Respir J. 2020;23:2002554.","journal-title":"Eur Respir J"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149\u201362.","journal-title":"Lancet Infect Dis."},{"key":"1701_CR6","doi-asserted-by":"publisher","first-page":"e242576","DOI":"10.1136\/bcr-2021-242576","volume":"14","author":"WH Chong","year":"2021","unstructured":"Chong WH, Ibrahim A, Saha BK. The evolution of invasive pulmonary aspergillosis on chest imaging in response to antifungal therapy. BMJ Case Rep. 2021;14:e242576.","journal-title":"BMJ Case Rep"},{"key":"1701_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","volume":"113","author":"WH Chong","year":"2021","unstructured":"Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115\u201329.","journal-title":"J Hosp Infect"},{"key":"1701_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"AFAD Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782\u201392.","journal-title":"Lancet Respir Med"},{"key":"1701_CR9","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524\u201335.","journal-title":"Intensive Care Med"},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71:1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"1701_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1701_CR14","doi-asserted-by":"crossref","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020;ciaa1065.","DOI":"10.1093\/cid\/ciaa1065"},{"key":"1701_CR15","unstructured":"Delli\u00e8re S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic P-A, et al. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2020; S1198-743X(20)30756-4.\u00a0"},{"key":"1701_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/jof6030105","volume":"6","author":"J-P Gangneux","year":"2020","unstructured":"Gangneux J-P, Reizine F, Guegan H, Pinceaux K, Le Balch P, Prat E, et al. Is the COVID-19 pandemic a good time to include Aspergillus molecular detection to categorize aspergillosis in ICU patients? A monocentric experience. J Fungi. 2020;6:105.","journal-title":"J Fungi"},{"key":"1701_CR17","doi-asserted-by":"publisher","first-page":"e0238825","DOI":"10.1371\/journal.pone.0238825","volume":"16","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, Rothe K, Spinner CD, Schneider J, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS One. 2021;16:e0238825.","journal-title":"PLoS One"},{"key":"1701_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","volume":"202","author":"S Van Biesen","year":"2020","unstructured":"Van Biesen S, Kwa D, Bosman RJ, Juffermans NP. Detection of invasive pulmonary aspergillosis in COVID-19 with nondirected BAL. Am J Respir Crit Care Med. 2020;202:1171\u20133.","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR19","doi-asserted-by":"crossref","unstructured":"V\u00e9lez Pintado M, Camiro-Z\u00fa\u00f1iga A, Aguilar Soto M, Cuenca D, Mercado M, Crabtree-Ramirez B, et al. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Med Mycol. 2021;59:828\u201333.","DOI":"10.1093\/mmy\/myab009"},{"key":"1701_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","volume":"24","author":"J Wang","year":"2020","unstructured":"Wang J, Yang Q, Zhang P, Sheng J, Zhou J, Qu T. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care. 2020;24:299.","journal-title":"Crit Care"},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/myc.13219","volume":"64","author":"G Segrelles-Calvo","year":"2021","unstructured":"Segrelles-Calvo G, Ara\u00fajo GRS, Llopis-Pastor E, Carrillo J, Hern\u00e1ndez-Hern\u00e1ndez M, Rey L, et al. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses. 2021;64:144\u201351.\u00a0","journal-title":"Mycoses"},{"key":"1701_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/myc.13259","volume":"64","author":"R Grootveld","year":"2021","unstructured":"van Grootveld R, van Paassen J, de Boer MGJ, Claas ECJ, Kuijper EJ, van der Beek MT, et al. Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate. Mycoses. 2021;64:641\u201350.\u00a0","journal-title":"Mycoses"},{"key":"1701_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13613-016-0156-2","volume":"6","author":"D Contou","year":"2016","unstructured":"Contou D, Dorison M, Rosman J, Schlemmer F, Gibelin A, Foulet F, et al. Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study. Ann Intensive Care. 2016;6:52.","journal-title":"Ann Intensive Care"},{"key":"1701_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2020","unstructured":"Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin J-M, et al. Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU. Am J Respir Crit Care Med. 2021;203:307\u201317.\u00a0","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/diagnostics10100807","volume":"10","author":"A Apostolopoulou","year":"2020","unstructured":"Apostolopoulou A, Esquer Garrigos Z, Vijayvargiya P, Lerner AH, Farmakiotis D. Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: a systematic review of the literature. Diagnostics. 2020;10:807.","journal-title":"Diagnostics"},{"key":"1701_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/myc.12498","volume":"59","author":"M Fliesser","year":"2016","unstructured":"Fliesser M, Wallstein M, Kurzai O, Einsele H, L\u00f6ffler J. Hypoxia attenuates anti-Aspergillus fumigatus immune responses initiated by human dendritic cells. Mycoses. 2016;59:503\u20138.","journal-title":"Mycoses"},{"key":"1701_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol"},{"key":"1701_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, Van den Abeele A-M, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically Ill patients. Am J Respir Crit Care Med. 2012;186:56\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"The RECOVERY Collaborative Group","year":"2020","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;38:693\u2013704.\u00a0","journal-title":"N Engl J Med"},{"key":"1701_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020;324:1330.","journal-title":"JAMA"},{"key":"1701_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/aas.13673","volume":"64","author":"MW Petersen","year":"2020","unstructured":"Petersen MW, Meyhoff TS, Helleberg M, Kj\u00e6r MN, Granholm A, Hjorts\u00f8 CJS, et al. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial\u2014protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2020;64:1365\u201375.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1701_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","volume":"324","author":"P-F Dequin","year":"2020","unstructured":"Dequin P-F, Heming N, Meziani F, Plantef\u00e8ve G, Voiriot G, Badi\u00e9 J, et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically Ill patients with COVID-19: a randomized clinical trial. JAMA. 2020;324:1298.","journal-title":"JAMA"},{"key":"1701_CR33","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307.","journal-title":"JAMA"},{"key":"1701_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/2049-6958-8-59","volume":"8","author":"N Tutar","year":"2013","unstructured":"Tutar N, Metan G, Ko\u00e7 AN, Yilmaz I, Bozkurt I, Simsek ZO, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Multidiscip Respir Med. 2013;8:59.","journal-title":"Multidiscip Respir Med"},{"key":"1701_CR35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782\u2013800.","journal-title":"Eur Respir J"},{"key":"1701_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1469-0691.2005.01143.x","volume":"11","author":"F Ader","year":"2005","unstructured":"Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect. 2005;11:427\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1701_CR37","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1086\/322793","volume":"184","author":"E Cenci","year":"2001","unstructured":"Cenci E, Mencacci A, Casagrande A, Mosci P, Bistoni F, Romani L. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis. 2001;184:610\u20137.","journal-title":"J Infect Dis"},{"key":"1701_CR38","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","volume":"2","author":"G Guaraldi","year":"2020","unstructured":"Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020;2:e474\u201384.","journal-title":"Lancet Rheumatol"},{"key":"1701_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, et al. Association between early treatment with tocilizumab and mortality among critically Ill patients with COVID-19. JAMA Intern Med. 2021;181:41\u201351.","journal-title":"JAMA Intern Med"},{"key":"1701_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","volume":"384","author":"C Salama","year":"2021","unstructured":"Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. Tocilizumab in patients hospitalized with COVID-19 pneumonia. N Engl J Med. 2021;384:20\u201330.","journal-title":"N Engl J Med"},{"key":"1701_CR41","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10096-020-03923-7","volume":"39","author":"F Waldeck","year":"2020","unstructured":"Waldeck F, Boroli F, Suh N, Wendel Garcia PD, Flury D, Notter J, et al. Influenza-associated aspergillosis in critically-ill patients\u2014a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39:1915\u201323.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1701_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","volume":"196","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Kolwijck E, Lestrade PPA, Hodiamont CJ, Rijnders BJA, van Paassen J, et al. Influenza-associated aspergillosis in critically Ill patients. Am J Respir Crit Care Med. 2017;196:524\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1701_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-021-03460-5","volume":"25","author":"M Maes","year":"2021","unstructured":"Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care Lond Engl. 2021;25:25.","journal-title":"Crit Care Lond Engl"},{"key":"1701_CR44","first-page":"451","volume":"27","author":"M Ripa","year":"2021","unstructured":"Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:451\u20137.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1701_CR45","first-page":"00137","volume":"S0002\u20139629","author":"WH Chong","year":"2021","unstructured":"Chong WH, Chieng H, Tiwari A, Beegle S, Feustel PJ, Ghalib S, et al. Incidence and risk factors for secondary pulmonary infections in patients hospitalized with coronavirus disease 2019 pneumonia. Am J Med Sci. 2021;S0002\u20139629:00137\u201343.","journal-title":"Am J Med Sci"},{"key":"1701_CR46","doi-asserted-by":"crossref","unstructured":"Hoenigl M. Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores. Clinical Infectious Diseases. 2020;ciaa1342.\u00a0","DOI":"10.1093\/cid\/ciaa1342"},{"key":"1701_CR47","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","volume":"2","author":"BE Kula","year":"2021","unstructured":"Kula BE, Clancy CJ, Hong Nguyen M, Schwartz IS. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe. 2021;2:e405\u201314.","journal-title":"Lancet Microbe"},{"key":"1701_CR48","doi-asserted-by":"publisher","first-page":"ofaa242","DOI":"10.1093\/ofid\/ofaa242","volume":"7","author":"GR Thompson Iii","year":"2020","unstructured":"Thompson Iii GR, Cornely OA, Pappas PG, Patterson TF, Hoenigl M, Jenks JD, et al. Invasive aspergillosis as an under-recognized superinfection in COVID-19. Open Forum Infect Dis. 2020;7:ofaa242.","journal-title":"Open Forum Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-021-01701-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T07:31:54Z","timestamp":1699515114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-021-01701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1007\/s15010-021-01701-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval and informed consent were not required for this study as it was a systematic review of previously published studies. The protocol for this review was registered and published in the International Prospective Register of Systematic Reviews (PROSPERO) under reference number CRD42021247177.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}